In bid to cure coronavirus, decade-old Actemra drug emerges as hope
China has approved the use of Swiss drugmaker Roche’s anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly